Erlotinib vs Fondaparinux Sodium

## Erlotinib vs Fondaparinux Sodium: Overview

This comparison examines the pharmacological differences between **Erlotinib** and **Fondaparinux Sodium**.

## Mechanism of Action

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Erlotinib — 36 hours; Fondaparinux Sodium — N/A.

## Chemical Properties

**Molecular Formula**: Erlotinib — C22H23N3O4; Fondaparinux Sodium — N/A.

**Molecular Weight**: Erlotinib — 393.4380 g/mol; Fondaparinux Sodium — N/A.

**Type**: Erlotinib — Small molecule; Fondaparinux Sodium — Oligosaccharide.